advertisement
Singh P 23
Showing records 1 to 23 | Display all abstracts from Singh P109584 Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety
Mathur MC
Indian Journal of Ophthalmology 2023; 71: 2500-2503
109803 Applications of artificial intelligence and bioinformatics methodologies in the analysis of ocular biofluid markers: a scoping review
Pucchio A; Pucchio A
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 1041-1091
109584 Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety
Ratnam PV
Indian Journal of Ophthalmology 2023; 71: 2500-2503
109803 Applications of artificial intelligence and bioinformatics methodologies in the analysis of ocular biofluid markers: a scoping review
Krance SH; Pur DR
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 1041-1091
109584 Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety
Saikumar SJ
Indian Journal of Ophthalmology 2023; 71: 2500-2503
109803 Applications of artificial intelligence and bioinformatics methodologies in the analysis of ocular biofluid markers: a scoping review
Pur DR
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 1041-1091
109584 Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety
John M
Indian Journal of Ophthalmology 2023; 71: 2500-2503
109803 Applications of artificial intelligence and bioinformatics methodologies in the analysis of ocular biofluid markers: a scoping review
Bhatti J
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 1041-1091
109584 Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety
Ravishankar S
Indian Journal of Ophthalmology 2023; 71: 2500-2503
109803 Applications of artificial intelligence and bioinformatics methodologies in the analysis of ocular biofluid markers: a scoping review
Bassi A
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 1041-1091
109584 Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety
Dinesh MB
Indian Journal of Ophthalmology 2023; 71: 2500-2503
109803 Applications of artificial intelligence and bioinformatics methodologies in the analysis of ocular biofluid markers: a scoping review
Manichavagan K
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 1041-1091
109584 Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety
Chandil P
Indian Journal of Ophthalmology 2023; 71: 2500-2503
109803 Applications of artificial intelligence and bioinformatics methodologies in the analysis of ocular biofluid markers: a scoping review
Brahmbhatt S; Aggarwal I
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 1041-1091
109584 Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety
Pahuja K; Cherlikar V
Indian Journal of Ophthalmology 2023; 71: 2500-2503
109803 Applications of artificial intelligence and bioinformatics methodologies in the analysis of ocular biofluid markers: a scoping review
Singh P
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 1041-1091
109584 Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety
Wadhwani S
Indian Journal of Ophthalmology 2023; 71: 2500-2503
109803 Applications of artificial intelligence and bioinformatics methodologies in the analysis of ocular biofluid markers: a scoping review
Virani A
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 1041-1091
109584 Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety
Bendale P
Indian Journal of Ophthalmology 2023; 71: 2500-2503
109803 Applications of artificial intelligence and bioinformatics methodologies in the analysis of ocular biofluid markers: a scoping review
Stanley M
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 1041-1091
109584 Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety
Hazari A
Indian Journal of Ophthalmology 2023; 71: 2500-2503
109803 Applications of artificial intelligence and bioinformatics methodologies in the analysis of ocular biofluid markers: a scoping review
Miranda RN; Felfeli T
Graefe's Archive for Clinical and Experimental Ophthalmology 2024; 262: 1041-1091
109584 Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety
Mishra R; Deshmukh S; Deshmukh S; Achlerkar RR; Shah DT; Hingorani C; Shah K; Topiwala P; Jani S; Rana VG; Majumdar NK; Chakrabarti D; Dey R; Halder D; Choudhury S; Kumar A; Das S; Nanda AK; Kumar VB; Dubey R; Kamdar GA; Pandey A; Kishanpuria S; Srivastava RM; Singh P; Verma SK; Sharma N; Gupta R
Indian Journal of Ophthalmology 2023; 71: 2500-2503